Hey Snackers,
RIP to the No. 2 pencil’s greatest foe: The SAT is officially going completely digital starting in 2024. Future high schoolers will never know the anxiety induced by oval bubbles.
Stocks slumped after Fed Chair Jerome Powell suggested that he plans to hike rates in March. Both the Dow Jones and the S&P 500 fell, and the tech-heavy Nasdaq closed nearly flat despite a boost from Microsoft — whose shares jumped 3% after reporting strong cloud sales.
“The Joe Rogan Experience”... just got more complicated. JRE is the world's largest podcast, with an estimated 11M listeners per episode. In 2020, Spotify signed a deal to make the pod Spotify-exclusive for a reported $100M. Now, a viral December episode is drawing fresh criticism:
I’m a pod-star, not a doctor... Rogan has said he is not anti-vax, and that he encourages "many" people to get vaccinated, but this isn't the first time he's been criticized for Covid misinfo. Spotify has removed thousands of episodes containing Covid misinfo in the past. It has also reportedly removed 42 JRE episodes, including ones featuring far-right activists — but none related to vaccines. As its pod business booms, critics want clearer moderation policies.
With great publishing power comes great responsibility… The calls to action were broader than JRE — they were directed at Spotify’s moderation policies (or lack thereof). Unlike many large platforms, Spotify doesn't appear to have a defined misinformation policy, or at least one that’s consistently enforced. Yet moderation will likely become a growing issue for Spotify as its business grows — just as it is for other social and streaming giants.
From “Shark Tank” to the aspirin aisle… Celeb investor Mark Cuban launched an online pharmacy designed to lower prices of 100 generic drugs. The Cost Plus Drug Co. aims to simplify healthcare’s complex biz model by cutting out intermediaries and selling drugs for wholesale prices — plus a fixed 15% markup.
Rattling big pill bottles… Nearly 80% of US prescriptions are managed by CVS, Cigna, and UnitedHealth. Critics say pharmacy heavyweights use complex clauses to drive up prices, and regulators are investigating the industry. Several companies are trying to fix healthcare’s pricing problem:
Price matters, but so does transparency… That’s why companies are pursuing more transparent alternatives to traditional pharma. Cost Plus can’t fully replace pharmacy behemoths (it only sells generic drugs) and its prices may not be lower than competitors’. But CP is building a Texas factory to make its own meds. And if it steals sales from juggernauts like CVS, it could help push the whole industry to become more transparent.
Authors of this Snacks own shares of: GM, Pfizer, Apple, Amazon, Microsoft, Walmart, CVS, Nvidia, Spotify, and Tesla
ID: 2008065